2015
DOI: 10.14748/ssmd.v1i2.1276
|View full text |Cite
|
Sign up to set email alerts
|

Application of α-adrenomimetic decongestants as chemical agents for gingival retraction

Abstract: Purpose: The purpose of this study is to observe, compare and evaluate the effect of two α-adrenomimetic decongestants which are clinically approved nasal and eye drops-0.05% xylometazoline hydrochloride and 0.05% tetrahydrozoline hydrochloride, when applied as chemical agents for chemo-mechanical retraction of free gingiva prior to impression making in fixed prosthodontics. Materials and methods: The study includes 90 prepared abutment teeth indicated for fixed prosthodontic treatment. α-adrenomimetic deconge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…At the beginning of each clinical visit, a preparation of the abutment teeth was done, including: removal of the temporary restoration, cleaning of the prepared hard dental tissues from the temporary cement, and retraction of the soft tissues using two retraction cords (Ultrapak, Ultradent Products Inc., USA). ) and an impregnating agent from the group of α-adrenomimetic decongestants (xylometazoline 0.05%, Warsaw Pharmaceutical Works Polfa SA, Poland) in order to clearly visualize the preparation margin (13). In both impression techniques, impressions were taken separately for the upper and lower jaw, as well as occlusal registration.…”
Section: Methodsmentioning
confidence: 99%
“…At the beginning of each clinical visit, a preparation of the abutment teeth was done, including: removal of the temporary restoration, cleaning of the prepared hard dental tissues from the temporary cement, and retraction of the soft tissues using two retraction cords (Ultrapak, Ultradent Products Inc., USA). ) and an impregnating agent from the group of α-adrenomimetic decongestants (xylometazoline 0.05%, Warsaw Pharmaceutical Works Polfa SA, Poland) in order to clearly visualize the preparation margin (13). In both impression techniques, impressions were taken separately for the upper and lower jaw, as well as occlusal registration.…”
Section: Methodsmentioning
confidence: 99%
“…The analysis of the data shows higher efficiency of 0.05% xylometazoline HCl (Xylometazolin) in comparison to the ophthalmic decongestant 0.05% tetrahydrozoline HCl (Visine). Xylometazoline provides a thicker layer of impression material which penetrates deeper than half the gingival groove's depth (12)(13)(14). The results obtained from our previous researches, as well as the data gathered from the literature sources, demonstrate that α-adrenergic sympathicomimetic decongestants -0.05% xylometazoline HCl, 0.05% tetrahydrozoline HCl and 10% phenylephrine HCl, achieve sufficient hemostasis, adequate reduction of the crevice fluid and effective retraction of the free gingiva, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…In search of the ideal chemical agent, researches revealed a new application for nasal and ophthalmic decongestantsoxymetazoline hydrochloride, xylometazoline hydrochloride, tetrahydrozoline hydrochloride, which belong to the group of α-adrenomimetic substances. It is proven that they lead to effective and reversible displacement of margo gingivalis without causing undesirable side effects on the oral and overall health of patients (11)(12)(13).…”
Section: Introductionmentioning
confidence: 99%